UK markets open in 7 hours 8 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.20 +0.25 (+0.32%) GOLD FUTURES
2,311.80 +2.20 (+0.10%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,174.38 +602.98 (+1.29%)
NanoViricides, Inc. (NNVC)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 03:06PM EDT
After hours:
| Previous close | 1.1300 |
| Open | 1.1550 |
| Bid | 1.1200 x 3100 |
| Ask | 1.2800 x 800 |
| Day's range | 1.1200 - 1.2000 |
| 52-week range | 1.0000 - 2.0000 |
| Volume | |
| Avg. volume | 29,634 |
| Market cap | 14.135M |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.8000 |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.50 |
ACCESSWIRENanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
NanoViricides, Inc. (NYSE American:NNVC) (the "Company") reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two oral drug products: (i) NV-CoV-2 Oral Syrup, and (ii) NV-CoV-2 Oral Gummies.
© 2024 Yahoo. All rights reserved.